Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron PharmafiledCriticalRegeneron Pharma
Publication of AR103810A1publicationCriticalpatent/AR103810A1/en
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
Se proporcionan composiciones y métodos para líneas celulares diseñadas genéticamente y sistemas de expresión que permiten la expresión de proteínas recombinantes en células eucariotas y su facilidad de aislamiento. También se proporcionan sistemas de expresión celular capaces de expresar una proteína de interés esencialmente libre de una proteína de célula hospedante ligada. Reivindicación 14: La célula hospedante de acuerdo con cualquiera de las reivindicaciones 1 - 13, en donde la célula comprende un fragmento de la proteina PLBD2.Compositions and methods for genetically designed cell lines and expression systems that allow the expression of recombinant proteins in eukaryotic cells and their ease of isolation are provided. Cellular expression systems capable of expressing a protein of interest essentially free of a bound host cell protein are also provided. Claim 14: The host cell according to any one of claims 1-13, wherein the cell comprises a fragment of the PLBD2 protein.
ARP160100522A2015-02-272016-02-29
MODIFICATION OF HOSPEDANT CELL PROTEIN
AR103810A1
(en)